Michael Kinley - KDA Director

KDA Stock  CAD 0.28  0.01  3.70%   

Director

Mr. Michael W. Kinley was appointed as Director of AlliancePharma Inc., with effect from 8 January 2015. Mr. Kinley received his Bachelor of Commerce degree from Mount Allison University in 1971 and his Chartered Accountant designation in Ontario in 1973. He earned his designation with KPMG, where he spent 20 years the last ten as a partner. During the past twenty years Mr. Kinley has served as an officer and director for a number of public companies listed on the TSX and TSX Venture Exchanges. Mr. Kinley will bring strong expertise and knowledge in accounting and management to the Board of APA. He will surely provide a strong and solid support to the management team of the Corporationrationration. since 2015.
Tenure 9 years
Address 1351, Notre Dame St. East, Thetford Mines, QC, Canada, G6G 0G5
Phone418-755-0821
Webhttps://groupekda.ca

KDA Management Efficiency

The company has return on total asset (ROA) of (0.1156) % which means that it has lost $0.1156 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1593) %, meaning that it generated substantial loss on money invested by shareholders. KDA's management efficiency ratios could be used to measure how well KDA manages its routine affairs as well as how well it operates its assets and liabilities. At this time, KDA's Total Assets are fairly stable compared to the past year. Other Assets is likely to climb to about 9 M in 2024, whereas Other Current Assets are likely to drop slightly above 249.3 K in 2024.
KDA Group has accumulated 1.67 M in total debt. KDA Group has a current ratio of 0.5, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist KDA until it has trouble settling it off, either with new capital or with free cash flow. So, KDA's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like KDA Group sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for KDA to invest in growth at high rates of return. When we think about KDA's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Agathe CoteiA Financial
60
Craig SkaugeOlympia Financial Group
43
Nicolas DarveauGarneauiA Financial
50
Monique MercieriA Financial
62
Claude LamoureuxiA Financial
77
David MillerCI Financial Corp
69
Emma GriffiniA Financial
46
Paul PerrowCI Financial Corp
55
Benoit DaignaultiA Financial
55
Brigette ChangAddorisioCI Financial Corp
42
William ButtCI Financial Corp
56
Thomas MuirCI Financial Corp
63
Louis TetuiA Financial
55
Edgar PangAdvent Wireless
N/A
Marc PouliniA Financial
56
Danielle MoriniA Financial
63
KDA Group Inc. provides pharmacy personnel replacement and vocational training services to health industry in the Province of Quebec, Canada. The company was formerly known as AlliancePharma Inc. and changed its name to KDA Group Inc. in February 2017. KDA GROUP operates under Medical Distribution classification in Canada and is traded on TSX Venture Exchange. KDA Group (KDA) is traded on TSX Venture Exchange in Canada and employs 14 people. KDA is listed under Health Care Providers & Services category by Fama And French industry classification.

Management Performance

KDA Group Leadership Team

Elected by the shareholders, the KDA's board of directors comprises two types of representatives: KDA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of KDA. The board's role is to monitor KDA's management team and ensure that shareholders' interests are well served. KDA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, KDA's outside directors are responsible for providing unbiased perspectives on the board's policies.
Stuart Elman, Director
Giuseppe DAprano, Chief Officer
MarieHelene Pinard, Operating Inc
Luc Olivier, Chief Officer
Yves Marmet, Member inc
JeanMarc Leveille, Member Planning
Marc Lemieux, President, Chief Executive Officer
Patrick Fernet, Director
Michael Kinley, Director
JeanPierre BSc, Chief Officer
Annie Mercier, Finance Director
Isabelle Begin, Chief Operating Officer, Executive Vice President - Pharmacy Services Division and Director
Sheldon Elman, Director
Pierre Monet, Secretary

KDA Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is KDA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for KDA Stock Analysis

When running KDA's price analysis, check to measure KDA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy KDA is operating at the current time. Most of KDA's value examination focuses on studying past and present price action to predict the probability of KDA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move KDA's price. Additionally, you may evaluate how the addition of KDA to your portfolios can decrease your overall portfolio volatility.